D-0603-2021 Class II Terminated

Recalled by Fresenius Medical Care Holdings, Inc. — Waltham, MA

FDA drug recall D-0603-2021 was initiated by Fresenius Medical Care Holdings, Inc. on Apr 28, 2021 and is designated Class II. Reason for recall: Temperature Abuse: Product exposed to temperature outside specified limits. The recall status is terminated (terminated Sep 17, 2021). Affected quantity: 48 cases.

Recall details

Product Type
Drugs
Report Date
Jun 16, 2021
Initiation Date
Apr 28, 2021
Termination Date
Sep 17, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
48 cases

Product description

Sodium Chloride 0.9%, USP, 1000 mL, Mfg by: Fresenius Medical Care North America, Waltham, MA 02451, NDC 46163-0300-10

Reason for recall

Temperature Abuse: Product exposed to temperature outside specified limits.

Distribution pattern

Nationwide within the United States

Code information

Lot #: 20NG02095, Exp. Date October 2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0603-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0603-2021. Report a data issue: hello@regdatalab.com.